Analytical Data
-
Gene name
C5orf35
- Application
-
Alternative Names
SETD9; C5orf35; SET domain-containing Protein 9; EC 2.1.1.-
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8NE22
-
Expression Region
1-299aa
-
AA Sequence
MPGRLLRGLW QRWRRYKYRF VPWIALNLSH NPRTLRYVPE ESKDKVISDE DVLGTLLKVF QALFLNDFNK QSEILSMLPE SVKSKYQDLL AVEHQGVKLL ENRHQQQSTF KPEEILYKTL GFSVAQATSS LISAGKGVFV TKGLVPKGAV VSMYPGTVYQ KYEPIFFQSI GNPFIFRCLD GVLIDGNDKG ISKVVYRSCN GRDRLGPLKM SDSTWLTSEI HNPLAVGQYV NNCSNDRAAN VCYQEFDVPA VFPIELKQYL PNIAYSYDKQ SPLRCVVLVA LRDINQGEEL FSNYYTIVS
-
Molecular Weight
60.6 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C5orf35, also known as chromosome 5 open reading frame 35, is a gene of interest in biomedical research due to its potential roles in various physiological and pathological processes. Initially discovered through genomic sequencing projects, C5orf35 has garnered attention because of its expression in several tissues, suggesting a possible involvement in diverse biological functions. Research indicates that C5orf35 may be implicated in immune responses and cellular stress mechanisms, prompting investigations into its role in diseases such as cancer and autoimmune disorders. The recombinant protein of C5orf35 serves as a valuable tool for studying its functional properties, interactions with other proteins, and effects on cellular pathways. By producing this protein in a controlled laboratory setting, researchers aim to elucidate C5orf35’s biological significance, explore its potential as a biomarker, and assess its viability as a therapeutic target. Ongoing studies involving the characterization of C5orf35’s structure and function may contribute to a deeper understanding of its role in health and disease, ultimately paving the way for novel diagnostic and therapeutic strategies.
